Milestone Pharmaceuticals Inc (MIST)
0.7701 -0.0300 (-3.75%) 13:32 ET [NASDAQ]
0.7700 x 100 0.7831 x 100
Realtime by (Cboe BZX)
0.7700 x 100 0.7831 x 100
Realtime 0.7902 -0.0099 (-) 09:23 ET
for Tue, Apr 1st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Operating Expenses | 12,348 | 9,616 | 9,662 | 10,476 | 13,800 |
Operating Income | -12,348 | -9,616 | -9,662 | -10,476 | -13,800 |
Interest Expense | 919 | 903 | 887 | 872 | 860 |
Other Income | 904 | 1,080 | 1,186 | 994 | 1,049 |
Pre-tax Income | -12,363 | -9,439 | -9,363 | -10,354 | -13,611 |
Net Income Continuous | -12,363 | -9,439 | -9,363 | -10,354 | -13,611 |
Net Income | $-12,363 | $-9,439 | $-9,363 | $-10,354 | $-13,611 |
EPS Basic Total Ops | -0.18 | -0.14 | -0.14 | -0.21 | -0.32 |
EPS Basic Continuous Ops | -0.18 | -0.14 | -0.14 | -0.21 | -0.32 |
EPS Diluted Total Ops | -0.18 | -0.14 | -0.14 | -0.21 | -0.32 |
EPS Diluted Continuous Ops | -0.18 | -0.14 | -0.14 | -0.21 | -0.32 |
EPS Diluted Before Non-Recurring Items | N/A | -0.14 | -0.14 | -0.21 | -0.32 |
EBITDA(a) | $-12,322 | $-9,591 | $-9,636 | $-10,448 | $-13,774 |